132
Views
4
CrossRef citations to date
0
Altmetric
Review

Uveitis Specialists Harnessing Disruptive Technology during the COVID-19 Pandemic and Beyond

&
Pages 296-303 | Received 15 Jan 2021, Accepted 17 Jan 2021, Published online: 23 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elif Arslanoglu Aydin, Semanur Ozdel, Pinar Cakar Ozdal, İlknur Bagrul, Esra Baglan, Serife Tuncez & Mehmet Bulbul. (2023) Changing face of non-infectious pediatric uveitis in the pre-pandemic and pandemic periods: a comparison study. Postgraduate Medicine 135:4, pages 418-423.
Read now
Ella H Leung, Jason Fan, Harry W Flynn$suffix/text()$suffix/text() & Thomas A Albini. (2022) Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare. Clinical Ophthalmology 16, pages 1-13.
Read now

Articles from other publishers (2)

Giselle Ricur, Joshua Reyes, Eduardo Alfonso & Raul Guillermo Marino. (2023) Surfing the COVID-19 Tsunami with Teleophthalmology: the Advent of New Models of Eye Care. Current Ophthalmology Reports 11:1, pages 1-12.
Crossref
Begoña de las Heras, Adam Daehnke, Kamal S Saini, Melissa Harris, Kenneth Morrison, Ariel Aguilo, Isagani Chico, Laura Vidal & Robin Marcus. (2022) Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients. DIGITAL HEALTH 8, pages 205520762210999.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.